Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27720366 | 0.98 | GPR52 (0.58) | GPR52KEAP1ALDH1A1FFAR1MAPT | |
| SCHEMBL8733598 | 0.88 | HDAC1 (0.62) | KEAP1MAPTHDAC2HDAC8HDAC6 | |
| SCHEMBL24504176 | 0.86 | MAPT (0.61) | MAPTHDAC2HDAC8HDAC6TDP1 | |
| SCHEMBL13310793 | 0.85 | THRB (0.50) | GPR52FFAR1HDAC2HDAC8HDAC6 | |
| SCHEMBL13892460 | 0.85 | MAPT (0.65) | MAPTHDAC2HDAC8HDAC6HDAC1 | |
| SCHEMBL27908866 | 0.84 | FFAR1 (0.49) | GPR52KEAP1FFAR1MAPTGAA | |
| SCHEMBL17897411 | 0.83 | FFAR1 (0.52) | GPR52FFAR1HDAC2HDAC8 | |
| SCHEMBL16812840 | 0.83 | THRB (0.43) | GPR52KEAP1FFAR1KMT2A | |
| SCHEMBL15272414 | 0.82 | ESR1 (0.50) | ALDH1A1MAPTHDAC2HDAC8TDP1 | |
| SCHEMBL2322246 | 0.81 | KEAP1 (0.61) | GPR52KEAP1ALDH1A1FFAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2847318-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | Marrone Bio Innovations, Inc. (US) | 2015-03-18 | — | — | EP | claimed |
| WO-2013138398-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2013-09-19 | — | — | WO | claimed |
| CN-1028098-C | Preparation of amino ketone compound | MONSANTO CO (US) | 1995-04-05 | — | — | CN | claimed |
| EP-4596230-A1 | MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC | Mitsubishi Chemical Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250178327-A1 | MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| CN-119731020-A | Multilayer structure, method for producing same, automobile component, aircraft component, and vibration-resistant material for carbon fiber reinforced plastic | 三菱化学株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-119638660-A | Preparation method of 3, 4-dihydropyran derivative | 华侨大学 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024157637-A1 | LAMINATE AND IMAGE DISPLAY DEVICE | 株式会社ダイセル | 2024-08-02 | — | — | WO | disclosed |
| WO-2024135086-A1 | PHOTOCURABLE COMPOSITION, UNDERCOAT LAYER, LAMINATE AND DISPLAY DEVICE | 株式会社ダイセル | 2024-06-27 | — | — | WO | disclosed |
| CN-118125919-A | Preparation method of conjugated triene compound | 华南理工大学 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024071139-A1 | MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC | 三菱ケミカル株式会社 | 2024-04-04 | — | — | WO | disclosed |
| EP-1723116-A2 | TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS | Merz Pharma GmbH & Co. KGaA (DE) | 2006-11-22 | — | — | EP | disclosed |
| CN-1730476-A | Aromatic amine ketone compounds, its synthetic method, the pharmaceutical composition that contains it and purposes | INST MATERIA MEDICA CAMS (CN) | 2006-02-08 | — | — | CN | disclosed |
| EP-1615636-A1 | BICYCLIC COMPOUNDS AS NR2B RECEPTOR ANTAGONISTS | PFIZER INC. (US) | 2006-01-18 | — | — | EP | disclosed |
| WO-2005082856-A2 | TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-09-09 | — | — | WO | disclosed |
| US-20050197361-A1 | Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-09-08 | — | — | US | disclosed |
| WO-2004089366-A1 | BICYCLIC COMPOUNDS AS NR2B RECEPTOR ANTAGONISTS | PFIZER JAPAN, INC. (JP) | 2004-10-21 | — | — | WO | disclosed |
| US-20040204409-A1 | Bicyclic compounds as NR2B receptor antagonists | ANDO KAZUO (JP) | 2004-10-14 | — | — | US | disclosed |
| CN-1140708-A | Synthetic method for lisinopril | WUZHOU PHARMACEUTICAL FACTORY (CN) | 1997-01-22 | — | — | CN | disclosed |
| US-4003911-A | ANTISECRETORY AGENTS, OXYTOCICS, BRONCHODILATORS, PLASTICIZERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204409-A1 | Bicyclic compounds as NR2B receptor antagonists | GRIN1, GRIN2B, GRIN2A | GPR52 68/4885KEAP1 2753/4885ALDH1A1 1871/4885 |
| US-20050197361-A1 | Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders | GRM5, GRIK5, GRIN2C | GPR52 55/4885KEAP1 258/4885ALDH1A1 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.